Dicerna Pharmaceuticals, Inc. Pre-Tax Profit Margin 2013-2021 | DRNA
Dicerna Pharmaceuticals, Inc. pre-tax profit margin from 2013 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2021-09-30 |
$0.19B |
$-0.12B |
-63.73% |
2021-06-30 |
$0.18B |
$-0.13B |
-72.07% |
2021-03-31 |
$0.18B |
$-0.12B |
-67.98% |
2020-12-31 |
$0.16B |
$-0.11B |
-68.90% |
2020-09-30 |
$0.13B |
$-0.12B |
-89.23% |
2020-06-30 |
$0.09B |
$-0.13B |
-140.45% |
2020-03-31 |
$0.06B |
$-0.12B |
-212.73% |
2019-12-31 |
$0.02B |
$-0.12B |
-504.17% |
2019-09-30 |
$0.02B |
$-0.10B |
-526.32% |
2019-06-30 |
$0.01B |
$-0.09B |
-676.92% |
2019-03-31 |
$0.01B |
$-0.10B |
-1111.11% |
2018-12-31 |
$0.01B |
$-0.09B |
-1125.00% |